Publicaciones en las que colabora con José Ramón Azanza Perea (67)

2020

  1. Bioequivalence Evaluation of Three Pediatric Oral Formulations of Bilastine in Healthy Subjects: Results from a Randomized, Open Label, Crossover Study

    European Journal of Drug Metabolism and Pharmacokinetics, Vol. 45, Núm. 2, pp. 265-272

  2. Single-Institution Experience in Clinical Trials during the COVID-19 Pandemic in Spain: Not So Bad after All?

    JCO Global Oncology

  3. The sars-cov-2 ivermectin navarra-isglobal trial (saint) to evaluate the potential of ivermectin to reduce covid-19 transmission in low risk, non-severe covid-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial

    Trials, Vol. 21, Núm. 1

2018

  1. Antibióticos. Generalidades

    Velázquez. Farmacología básica y clínica (Editorial Médica Panamericana), pp. 715-728

  2. Pharmacological profile of isavuconazole

    Revista Iberoamericana de Micologia

2017

  1. Dalbavancina: parámetros farmacocinéticos y farmacodinámicos

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 35, pp. 22-27

2015

  1. Monoclonal antibodies: Pharmacokinetics as a basis for new dosage regimens?

    Journal of Oncology Pharmacy Practice, Vol. 21, Núm. 5, pp. 370-376

2014

  1. Anidulafungin dosing in critically ill patients with continuous venovenous haemodiafiltration

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 6, pp. 1620-1623

  2. Pharmacokinetics of anidulafungin during albumin dialysis

    Critical Care

  3. Pharmacology of the antifungals used in the treatment of aspergillosis

    Revista Iberoamericana de Micologia, Vol. 31, Núm. 4, pp. 255-261

  4. Quinolonas: sulfamidas: trimetoprima: cotrimoxazol: nitrofurantoína: antisépticos

    Farmacología humana (Elsevier), pp. 1027-1043

  5. Randomized pharmacokinetic study comparing subcutaneous and intravenous palonosetron in cancer patients treated with platinum based chemotherapy

    PLoS ONE, Vol. 9, Núm. 2

2013

  1. Critical appraisal of bilastine for the treatment of allergic rhinoconjunctivitis and urticaria

    Therapeutics and Clinical Risk Management, Vol. 9, Núm. 1, pp. 197-205

  2. Effect of glucose concentration on the stability of daptomycin in peritoneal solutions

    Peritoneal Dialysis International

  3. Oral availability of bilastine

    Clinical Drug Investigation, Vol. 33, Núm. 5, pp. 375-381

2011

  1. Bilastine for the relief of allergy symptoms

    Drugs of Today, Vol. 47, Núm. 4, pp. 251-262

2010

  1. Simultaneous determination of diosmin and diosmetin in human plasma by ion trap liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry: Application to a clinical pharmacokinetic study

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 51, Núm. 4, pp. 875-881

2009

  1. A fast reverse-phase high performance liquid chromatographic tandem mass spectrometry assay for the quantification of clindamycin in plasma and saliva using a rapid resolution package

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 50, Núm. 4, pp. 649-654

2008

  1. Adverse effects and interactions of the new antibiotics active against Gram-positive cocci

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. SUPPL. 2, pp. 69-76

  2. Bioequivalence of two oral formulations of triflusal capsules in healthy volunteers

    Arzneimittel-Forschung/Drug Research, Vol. 58, Núm. 6, pp. 283-287